Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Advair Diskus 100/50
DRUG
2 trials
Sponsors
Roxane Laboratories
, Respirent Pharmaceuticals Co Ltd.
Conditions
Asthma
Bioequivalence
Phase 1
Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
NCT05697003
Respirent Pharmaceuticals Co Ltd.
Bioequivalence
Start: 2023-02-17
End: 2023-05-01
Target: 34
Updated: 2023-03-09
Unknown Phase
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
Completed
NCT02649478
Roxane Laboratories
Asthma
Start: 2014-08-31
End: 2015-11-30
Updated: 2018-01-23